Fort Collins-based Vet DC:
"VetDC was founded to take advantage of another trend: Pharmaceutical companies increasingly are testing their drugs on pets to get an early read on how the drug might work in people.
For instance, Gilead Sciences stopped work on a drug it was developing to treat lymphoma in people. But studies had already shown “beautiful data in people’s pets,” said Steven Roy, a former Amgen executive who runs VetDC. So VetDC is now developing that drug for lymphoma in dogs."
Link to The New York Times
Link to the overview of VetDC's 2012 winning Venture Showcase presentation
Quoting from the CBSA website:
"Four emerging life science companies will be selected to present at the 2014 BioWest Venture Showcase to pitch their technology and business plan to a panel of bioscience experts and investors. One outstanding company will be selected for $7,500 cash award, announced at the BioWest Closing Reception."
Link for more information about BioWest 2014